To the central content area
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

4728 Sunmax
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
MAGNET LIN LIN MING YI Guo Mei-Xin 06-5053288 1F., No.10, Lane 31, Sec. 1, Huandong Rd., Sinshih Dist.,Tainan City 744, Taiwan (R.O.C.) 2012/01/10
Industry Main Business
Biotechnology and Medical Care SunMax Biotechnology Co. Ltd., established in Feb. 2001, has been the first company of collagen R&D and manufacture in Taiwan. SunMax entered Tainan Science Park in July 2001, and then acquires Medical Device GMP certificate in January 2004. Earlier in Taiwan, biomedical collagen material and related products depended on importation, but most of them are extracted from bovines with potential BSE (Bovine Spongiform Encephalopathy). In 1995, under the supervision of key SunMax technical team in the US, SunMax R&D successfully developed an extraction and purification process to produce high purity medical grade collagen from SPF (Specific Pathogen Free) porcine skin in Taiwan. The process was scaled up in a GMP facility in Tainan Science Park.
Market Information ( 2021/12/03 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
13.017 79.90  79.30  79.30  0.00  16 0.02 2,732 18
Trading method Fun
price or
on T day
Announcement of Irregularity
TPEx measures
With warrants Can be shorted or margined? Detail
Normal N N N Y Y Today History
Financial Reports
Cash Flows Items
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.